(PDF) Association of Calnexin With Mutant Peripheral Myelin

Association of Calnexin With Mutant Peripheral Myelin Protein-22 Ex Vivo: A Basis for "Gain-Of-Function" ER Diseases

Proceedings of the National Academy of Sciences of the United States of America - United States

doi 10.1073/pnas.152621799

Full Text

Abstract

Available in full text

Categories

Multidisciplinary

Date

July 15, 2002

Authors

J. J. M. Bergeron

Publisher

Proceedings of the National Academy of Sciences

Related search

Peripheral Myelin Protein-22 Is Expressed in CNS Myelin

Translational Neuroscience

English

Peripheral ER Structure and Function

Current Opinion in Cell Biology

English

Enhanced Suppressive Function of Regulatory T Cells From Patients With Immune-Mediated Diseases Following Successful Ex Vivo Expansion

Clinical Immunology

English

Downregulation of the Human Peripheral Myelin Protein 22 Gene by miR-29a in Cellular Models of Charcot–Marie–Tooth Disease

Molecular Medicine

Molecular Biology

English

The Transcription and Expression Profile of P53N236S Mutant Reveals New Aspects of Gain of Function for Mutant P53

Molecular Biology

Structural Biology

English

The Transcription and Expression Profile of P53N236S Mutant Reveals New Aspects of Gain-Of-Function for Mutant P53

Molecular Biology

Structural Biology

English

Calnexin, an ER-induced Protein, Is a Prognostic Marker and Potential Therapeutic Target in Colorectal Cancer

Journal of Translational Medicine

Molecular Biology

English

Peripheral Myelin Protein 2 – A Novel Cluster of Mutations Causing Charcot-Marie-Tooth Neuropathy

Orphanet Journal of Rare Diseases

English

Pediatric Intensive Care: Immunomodulation With Activated Protein C Ex Vivo

Frontiers in Pediatrics

English